A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

Bibliographic Details
Main Authors:	Diaz-Padilla, I, Siu, L L, San Pedro-Salcedo, M, Razak, A R A, Colevas, A D, Shepherd, F A, Leighl, N B, Neal, J W, Thibault, A, Liu, L, Lisano, J, Gao, B, Lawson, E B, Wakelee, H A
Format:	Online
Language:	English
Published:	Nature Publishing Group 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419963/

id	pubmed-3419963
recordtype	oai_dc
spelling	pubmed-34199632013-08-07 A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours Diaz-Padilla, I Siu, L L San Pedro-Salcedo, M Razak, A R A Colevas, A D Shepherd, F A Leighl, N B Neal, J W Thibault, A Liu, L Lisano, J Gao, B Lawson, E B Wakelee, H A Clinical Study Nature Publishing Group 2012-08-07 2012-07-17 /pmc/articles/PMC3419963/ /pubmed/22805331 http://dx.doi.org/10.1038/bjc.2012.319 Text en Copyright © 2012 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Diaz-Padilla, I Siu, L L San Pedro-Salcedo, M Razak, A R A Colevas, A D Shepherd, F A Leighl, N B Neal, J W Thibault, A Liu, L Lisano, J Gao, B Lawson, E B Wakelee, H A
spellingShingle	Diaz-Padilla, I Siu, L L San Pedro-Salcedo, M Razak, A R A Colevas, A D Shepherd, F A Leighl, N B Neal, J W Thibault, A Liu, L Lisano, J Gao, B Lawson, E B Wakelee, H A A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
author_facet	Diaz-Padilla, I Siu, L L San Pedro-Salcedo, M Razak, A R A Colevas, A D Shepherd, F A Leighl, N B Neal, J W Thibault, A Liu, L Lisano, J Gao, B Lawson, E B Wakelee, H A
author_sort	Diaz-Padilla, I
title	A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
title_short	A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
title_full	A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
title_fullStr	A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
title_full_unstemmed	A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
title_sort	phase i dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
description
publisher	Nature Publishing Group
publishDate	2012
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419963/
_version_	1611549944822366208

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

Similar Items